Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 17 5 2022
medline: 23 6 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

Academic medical centers could play an important role in increasing access to and uptake of SARS-CoV-2 vaccines, especially in Black and Latino communities that have been disproportionately affected by the pandemic. This article describes the vaccination program developed by the Boston Medical Center (BMC) health system (New England's largest safety-net health system), its affiliated community health centers (CHCs), and community partners. The program was based on a conceptual framework for community interventions and aimed to increase equitable access to vaccination in the hardest-hit communities through community-based sites in churches and community centers, mobile vaccination events, and vaccination on the BMC campus. Key strategies included a communication campaign featuring trusted messengers, a focus on health equity, established partnerships with community leaders and CHCs, and strong collaboration with local health departments and the Commonwealth of Massachusetts to ensure equitable allocation of the vaccine supply. Process factors involved the use of robust analytics relying on the Centers for Disease Control and Prevention's Social Vulnerability Index (SVI). The vaccination program administered 109 938 first doses, with 94 703 (86%) given at community sites and 2466 (2%) given at mobile sites. Mobile vaccination events were key in reaching younger people living in locations with the highest SVIs. Challenges included the need for a robust operational infrastructure and mistrust of the health system given the long history of economic disinvestment in the surrounding community. The BMC model could serve as a blueprint for other medical centers interested in implementing programs aimed at increasing vaccine uptake during a pandemic and in developing an infrastructure to address other health-related disparities.

Identifiants

pubmed: 35576586
doi: 10.7326/M22-0028
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

879-884

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA044085
Pays : United States

Auteurs

Sabrina A Assoumou (SA)

Section of Infectious Diseases, Department of Medicine, Boston Medical Center, and Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts (S.A.A., C.M.P.).

Alicia Peterson (A)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Ellen Ginman (E)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Thea James (T)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Cassandra M Pierre (CM)

Section of Infectious Diseases, Department of Medicine, Boston Medical Center, and Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts (S.A.A., C.M.P.).

Sebastian Hamilton (S)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Sheila Chapman (S)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

John Goldie (J)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Robert Koenig (R)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Elena Mendez-Escobar (E)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Hannah Leaver (H)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Robert Graham (R)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Renee Crichlow (R)

Codman Square Health Center, Boston, Massachusetts (R.C., T.W., S.Cotterell).

Tarsha Weaver (T)

Codman Square Health Center, Boston, Massachusetts (R.C., T.W., S.Cotterell).

Sandra Cotterell (S)

Codman Square Health Center, Boston, Massachusetts (R.C., T.W., S.Cotterell).

Guale Valdez (G)

Mattapan Community Health Center, Boston, Massachusetts (G.V.).

Denise De Las Nueces (D)

Boston Health Care for the Homeless Program, Boston, Massachusetts (D.D.).

Nancy A Scott (NA)

Boston University School of Public Health, Boston, Massachusetts (N.A.S.).

Benjamin P Linas (BP)

Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, and Boston University School of Public Health, Boston, Massachusetts (B.P.L.).

Petrina Martin Cherry (PM)

Boston Medical Center, Boston, Massachusetts (A.P., E.G., T.J., S.H., S.Chapman, J.G., R.K., E.M., H.L., R.G., P.M.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH